Distribuzione geografica
Continente #
NA - Nord America 13942
EU - Europa 8825
AS - Asia 6140
OC - Oceania 420
AF - Africa 349
SA - Sud America 333
Continente sconosciuto - Info sul continente non disponibili 34
Totale 30043
Nazione #
US - Stati Uniti d'America 13310
CN - Cina 3107
IT - Italia 2589
GB - Regno Unito 1184
FR - Francia 1130
DE - Germania 1019
JP - Giappone 758
CA - Canada 484
IN - India 449
ES - Italia 404
AU - Australia 376
NL - Olanda 351
BE - Belgio 319
HK - Hong Kong 272
KR - Corea 254
IE - Irlanda 236
TW - Taiwan 183
CZ - Repubblica Ceca 174
TR - Turchia 170
RU - Federazione Russa 167
SE - Svezia 155
CH - Svizzera 141
ZA - Sudafrica 131
ID - Indonesia 127
BR - Brasile 125
NO - Norvegia 111
SG - Singapore 110
MX - Messico 109
IR - Iran 107
PL - Polonia 104
AT - Austria 97
GR - Grecia 94
TH - Thailandia 94
RO - Romania 89
VN - Vietnam 89
PT - Portogallo 86
EG - Egitto 65
IL - Israele 65
CL - Cile 64
DK - Danimarca 64
PK - Pakistan 58
UA - Ucraina 57
PH - Filippine 49
AR - Argentina 45
CO - Colombia 45
NZ - Nuova Zelanda 42
MY - Malesia 41
NG - Nigeria 39
HU - Ungheria 33
MA - Marocco 33
FI - Finlandia 31
HR - Croazia 30
MK - Macedonia 30
BG - Bulgaria 27
SA - Arabia Saudita 25
EU - Europa 24
LT - Lituania 24
PE - Perù 24
IQ - Iraq 23
JO - Giordania 20
MO - Macao, regione amministrativa speciale della Cina 20
RS - Serbia 20
LB - Libano 19
TN - Tunisia 18
KE - Kenya 15
KH - Cambogia 14
QA - Qatar 13
CY - Cipro 11
EC - Ecuador 11
AP - ???statistics.table.value.countryCode.AP??? 10
BA - Bosnia-Erzegovina 10
BD - Bangladesh 10
SI - Slovenia 10
SK - Slovacchia (Repubblica Slovacca) 10
AE - Emirati Arabi Uniti 9
GT - Guatemala 8
PS - Palestinian Territory 8
TT - Trinidad e Tobago 8
VE - Venezuela 8
DZ - Algeria 7
LU - Lussemburgo 7
LY - Libia 7
SD - Sudan 7
CU - Cuba 6
SY - Repubblica araba siriana 6
BY - Bielorussia 5
KW - Kuwait 5
LV - Lettonia 5
UY - Uruguay 5
AM - Armenia 4
BO - Bolivia 4
CM - Camerun 4
CR - Costa Rica 4
GE - Georgia 4
GH - Ghana 4
MT - Malta 4
BN - Brunei Darussalam 3
HN - Honduras 3
IS - Islanda 3
OM - Oman 3
Totale 29995
Città #
Fairfield 1277
Milan 1015
Houston 847
Ashburn 737
Woodbridge 722
Seattle 610
Santa Cruz 564
Buffalo 543
Ann Arbor 455
Cambridge 434
Beijing 419
Shanghai 384
Wilmington 330
Guangzhou 220
Tokyo 212
Dublin 199
Southend 199
Nanjing 192
Chicago 172
Wuhan 161
Paris 147
New York 141
San Diego 137
Taipei 132
Ottawa 130
Los Angeles 126
Hangzhou 123
London 116
Boardman 112
Rome 108
Central 103
Chengdu 96
San Francisco 94
Las Vegas 93
Shenyang 92
Seoul 84
Duncan 81
Toronto 78
Changsha 77
Jinan 72
Phoenix 72
Munich 68
Central District 67
Muizenberg 67
Redmond 66
Berlin 65
Boston 65
Gent 65
Dallas 64
Madrid 63
Singapore 63
Changchun 62
Mountain View 59
Bengaluru 58
Fuzhou 58
Vitry-sur-Seine 58
Barcelona 57
Fleming Island 57
Sydney 54
Clearwater 53
Hefei 51
Provo 51
Villejuif 48
San Jose 47
Brooklyn 46
Istanbul 46
Zhengzhou 46
Merelbeke 45
Santa Clara 45
Brussels 44
Ivry-sur-Seine 44
Amsterdam 43
Athens 43
Milpitas 43
Melbourne 42
Rho 42
Xian 42
Atlanta 41
Philadelphia 39
Utrecht 37
Vienna 37
Henderson 36
Mumbai 36
Rochester 36
Harbin 35
Heidelberg 35
Portland 35
Villeneuve-le-Roi 35
Delhi 34
University Park 34
Dong Ket 33
Osaka 33
Tianjin 33
Oslo 32
Birmingham 30
Jakarta 30
Mainz 30
Manchester 30
Stockholm 30
Fremont 29
Totale 14623
Nome #
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors, file dfa8b999-c359-748b-e053-3a05fe0a3a96 2335
Cetuximab for treating non-small cell lung cancer, file dfa8b99d-3c41-748b-e053-3a05fe0a3a96 1292
A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases, file dfa8b990-f52d-748b-e053-3a05fe0a3a96 1030
4th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 4), file dfa8b99d-1cb5-748b-e053-3a05fe0a3a96 902
Biologic therapy for advanced breast cancer : recent advances and future directions, file dfa8b9a5-fa2f-748b-e053-3a05fe0a3a96 819
Entinostat for the treatment of breast cancer, file dfa8b99f-34e8-748b-e053-3a05fe0a3a96 684
Association of Breast Cancer Irradiation With Cardiac Toxic Effects : A Narrative Review, file dfa8b9a6-1c5c-748b-e053-3a05fe0a3a96 658
Margetuximab for the treatment of HER2-positive metastatic breast cancer, file dfa8b9a6-578b-748b-e053-3a05fe0a3a96 603
Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO clinical practice guidelines, file dfa8b99b-c6c1-748b-e053-3a05fe0a3a96 566
Phase I study of lysine-specific demethylase 1 inhibitor, CC-90011, in patients with advanced solid tumors and relapsed/refractory non-hodgkin lymphoma A C, file dfa8b9a6-6dcd-748b-e053-3a05fe0a3a96 548
Estimating the Benefits of Therapy for Early Stage Breast Cancer The St Gallen International Consensus Guidelines for the Primary Therapy of Early Breast Cancer 2019, file dfa8b99f-2ecd-748b-e053-3a05fe0a3a96 525
Intracranial efficacy and survival with tucatinib plus trastuzumab and capecitabine for previously treated HER2-positive breast cancer with brain metastases in the HER2CLIMB trial, file dfa8b9a5-e350-748b-e053-3a05fe0a3a96 512
Safety, Tolerability, and Management of Toxic Effects of Phosphatidylinositol 3-Kinase Inhibitor Treatment in Patients with Cancer: A Review, file dfa8b99f-1379-748b-e053-3a05fe0a3a96 495
Edoxaban for Cancer-Associated Venous Thromboembolism, file dfa8b99d-2043-748b-e053-3a05fe0a3a96 462
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies, file dfa8b9a9-b87a-748b-e053-3a05fe0a3a96 456
Progresses toward precision medicine in RET-altered solid tumors, file dfa8b9a5-d2cc-748b-e053-3a05fe0a3a96 447
Ribociclib plus letrozole in early breast cancer : a presurgical, window-of-opportunity study, file dfa8b99a-e235-748b-e053-3a05fe0a3a96 398
Obesity increases the incidence of distant metastases in oestrogen receptor-negative human epidermal growth factor receptor 2-positive breast cancer patients, file dfa8b990-bfba-748b-e053-3a05fe0a3a96 385
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET), file dfa8b9a7-17d2-748b-e053-3a05fe0a3a96 375
Managing side effects of immune checkpoint inhibitors in breast cancer, file dfa8b9a7-30c4-748b-e053-3a05fe0a3a96 368
De-escalating and escalating treatments for early-stage breast cancer : the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017, file dfa8b999-0dc7-748b-e053-3a05fe0a3a96 338
Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer, file dfa8b9a6-3a03-748b-e053-3a05fe0a3a96 325
3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3), file dfa8b99b-f73d-748b-e053-3a05fe0a3a96 298
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies, file dfa8b9a6-3470-748b-e053-3a05fe0a3a96 294
Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer, file dfa8b99c-0555-748b-e053-3a05fe0a3a96 276
A clinical perspective on escalating or de-escalating adjuvant therapy in HER2+ breast cancer, file dfa8b99d-1c42-748b-e053-3a05fe0a3a96 269
Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis, file dfa8b99a-7737-748b-e053-3a05fe0a3a96 263
Three-year follow-up from a phase 3 study of SB3 (a trastuzumab biosimilar) versus reference trastuzumab in the neoadjuvant setting for human epidermal growth factor receptor 2-positive breast cancer, file dfa8b99f-49cf-748b-e053-3a05fe0a3a96 262
RNAi screens identify CHD4 as an essential gene in breast cancer growth, file dfa8b996-deda-748b-e053-3a05fe0a3a96 254
Lucitanib for the treatment of HRþ/HER2- Metastatic breast cancer : Results from the multicohort phase II FINESSE study, file dfa8b9a5-c331-748b-e053-3a05fe0a3a96 248
Phase I/Ib clinical trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination With Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors, file dfa8b9a7-2f71-748b-e053-3a05fe0a3a96 243
Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment, file dfa8b99e-b250-748b-e053-3a05fe0a3a96 235
Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in AURORA, the Breast International Group (BIG) molecular screening initiative, file dfa8b9a7-8e60-748b-e053-3a05fe0a3a96 234
Therapeutic Cancer Vaccines Revamping: Technology Advancements and Pitfalls, file dfa8b9a7-e797-748b-e053-3a05fe0a3a96 228
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer, file dfa8b9a8-1405-748b-e053-3a05fe0a3a96 224
3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3), file dfa8b99b-c12d-748b-e053-3a05fe0a3a96 210
Recent advances in triple negative breast cancer: the immunotherapy era, file dfa8b99f-4765-748b-e053-3a05fe0a3a96 208
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes, file dfa8b991-ea52-748b-e053-3a05fe0a3a96 200
Expression of tumor-associated antigens in breast cancer subtypes, file dfa8b9a0-784e-748b-e053-3a05fe0a3a96 195
Defining the immunogram of breast cancer: a focus on clinical trials, file dfa8b99f-491d-748b-e053-3a05fe0a3a96 182
New approaches for improving outcomes in breast cancer in Europe, file dfa8b99a-fb1e-748b-e053-3a05fe0a3a96 181
Modulation of epidermal growth factor receptor status by chemotherapy in patients with locally advanced non-small-cell lung cancer is rare, file dfa8b99e-2bad-748b-e053-3a05fe0a3a96 178
Barriers to the use of trastuzumab for HER2+ breast cancer and the potential impact of biosimilars : a physician survey in the united states and emerging markets, file dfa8b99a-c2e6-748b-e053-3a05fe0a3a96 177
Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic, file dfa8b9a2-7715-748b-e053-3a05fe0a3a96 168
Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trial, file dfa8b9a6-799d-748b-e053-3a05fe0a3a96 165
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3), file dfa8b99a-cbe7-748b-e053-3a05fe0a3a96 160
Mortality in patients with cancer and coronavirus disease 2019 : A systematic review and pooled analysis of 52 studies, file dfa8b9a5-dfdd-748b-e053-3a05fe0a3a96 157
Gemcitabine-induced systemic capillary leak syndrome, file dfa8b99e-dab9-748b-e053-3a05fe0a3a96 153
Gender-related challenges facing oncologists: The results of the ESMO Women for Oncology Committee survey, file dfa8b99d-0c93-748b-e053-3a05fe0a3a96 152
Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial, file dfa8b99f-7014-748b-e053-3a05fe0a3a96 150
4-Aminobiphenyl-DNA adducts in laryngeal tissue and smoking habits: an immunohistochemical study, file dfa8b99e-a8c7-748b-e053-3a05fe0a3a96 148
A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors, file dfa8b99d-0abc-748b-e053-3a05fe0a3a96 145
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5), file dfa8b9a5-d645-748b-e053-3a05fe0a3a96 144
Highlights from the 14th St Gallen International Breast Cancer Conference 2015 in Vienna: Dealing with classification, prognostication, and prediction refinement to personalize the treatment of patients with early breast cancer, file dfa8b99b-fff7-748b-e053-3a05fe0a3a96 139
Repurposing anticancer drugs for the management of COVID-19, file dfa8b9a5-e66e-748b-e053-3a05fe0a3a96 138
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer ☆, file 556420d7-831c-4b3c-980c-836305f9953d 135
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden, file dfa8b9a3-69fe-748b-e053-3a05fe0a3a96 135
Phase I study of twelve-day prolonged infusion of high-dose ifosfamide and doxorubicin as first-line chemotherapy in adult patients with advanced soft tissue sarcomas, file dfa8b99f-3802-748b-e053-3a05fe0a3a96 132
Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast Cancer: A Phase 3 Randomized Clinical Trial, file dfa8b9a6-2d2b-748b-e053-3a05fe0a3a96 132
Extended adjuvant chemotherapy in triple-negative breast cancer, file dfa8b99e-4fe9-748b-e053-3a05fe0a3a96 131
Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan, file dfa8b99a-ec4c-748b-e053-3a05fe0a3a96 129
Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers, file dfa8b9a5-cf5c-748b-e053-3a05fe0a3a96 128
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic : An International Collaborative Group, file dfa8b9a5-d4ef-748b-e053-3a05fe0a3a96 127
Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study, file dfa8b9a5-dd3c-748b-e053-3a05fe0a3a96 127
Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer, file dfa8b99b-d3ca-748b-e053-3a05fe0a3a96 126
Mismatch Repair Deficiency as a Predictive Biomarker for Immunotherapy Efficacy, file dfa8b99b-1c98-748b-e053-3a05fe0a3a96 125
Report on the status of women occupying leadership roles in oncology, file dfa8b99d-0c90-748b-e053-3a05fe0a3a96 125
Immunohistochemical quantitation of 4-aminobiphenyl-DNA adducts and p53 nuclear overexpression in T1 bladder cancer of smokers and nonsmokers, file dfa8b99e-f922-748b-e053-3a05fe0a3a96 125
Immunosuppression and Multiple Primary Malignancies in Kidney-Transplanted Patients : a Single-Institute Study, file dfa8b99a-a57b-748b-e053-3a05fe0a3a96 124
Talking to patients about biosimilars, file dfa8b99d-1cad-748b-e053-3a05fe0a3a96 123
WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells, file dfa8b9a2-ebc7-748b-e053-3a05fe0a3a96 123
Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: Back to the future?, file dfa8b99e-e9d5-748b-e053-3a05fe0a3a96 122
Emerging issues related to COVID-19 vaccination in patients with cancer, file dfa8b9a7-6ebb-748b-e053-3a05fe0a3a96 121
Are all cyclin-dependent kinases 4/6 inhibitors created equal?, file dfa8b99f-7b71-748b-e053-3a05fe0a3a96 120
Bone scan had no role in the staging of 765 consecutive operable T1-2N0-1 breast cancer patients without skeletal symptoms, file dfa8b99e-b786-748b-e053-3a05fe0a3a96 118
Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer : a systematic review, file dfa8b9a7-0a7a-748b-e053-3a05fe0a3a96 117
Adherence to COVID-19 vaccines in cancer patients: promote it and make it happen!, file dfa8b9a7-b663-748b-e053-3a05fe0a3a96 117
A Phase I Study of LSZ102, an Oral Selective Estrogen Receptor Degrader, With or Without Ribociclib or Alpelisib, in Patients with Estrogen Receptor-Positive Breast Cancer, file dfa8b9a7-e61f-748b-e053-3a05fe0a3a96 116
A phase 2 randomized, double-blinded, controlled study of ONT-380 vs. placebo in combination with capecitabine (C) and trastuzumab (T) in patients with pretreated HER2+ unresectable locally advanced or metastatic breast carcinoma (MBC), file dfa8b99b-e7f7-748b-e053-3a05fe0a3a96 114
Management of cardiac disease in cancer patients throughout oncological treatment : ESMO consensus recommendations, file dfa8b9a5-c8c3-748b-e053-3a05fe0a3a96 114
The PROMISe to increase precision in adjuvant therapy for early breast cancer: To “Type” or to “Print”?, file dfa8b99d-1ca8-748b-e053-3a05fe0a3a96 113
Impact of autoimmune diseases on outcome of patients with early breast cancer, file dfa8b99a-707b-748b-e053-3a05fe0a3a96 112
QTc prolongation assessment in anticancer drug development : clinical and methodological issues, file dfa8b99e-ae09-748b-e053-3a05fe0a3a96 112
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication, file dfa8b9a9-e16c-748b-e053-3a05fe0a3a96 111
Immune checkpoint blockade in cancer treatment : a double-edged sword cross-targeting the host as an "innocent bystander", file dfa8b99a-d059-748b-e053-3a05fe0a3a96 110
Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer, file dfa8b99a-e29a-748b-e053-3a05fe0a3a96 107
Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter, file dfa8b99e-b960-748b-e053-3a05fe0a3a96 107
Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date., file dfa8b99a-822e-748b-e053-3a05fe0a3a96 106
Breast carcinoma in elderly women : features of disease presentation, choice of local and systemic treatments compared with younger postmenopausal patients, file dfa8b99e-e115-748b-e053-3a05fe0a3a96 104
Re: Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer, file dfa8b99e-e1a0-748b-e053-3a05fe0a3a96 104
Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis, file dfa8b99f-5114-748b-e053-3a05fe0a3a96 103
Lessons from the first ecancer symposium on angiogenesis in gastric cancer, file dfa8b99a-740b-748b-e053-3a05fe0a3a96 102
Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naive patients with advanced non-small-cell lung cancer, file dfa8b99f-6c8a-748b-e053-3a05fe0a3a96 101
Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology, file dfa8b9a6-3cb1-748b-e053-3a05fe0a3a96 101
Understanding the role of comparative clinical studies in the development of oncology biosimilars, file dfa8b9a5-e5e5-748b-e053-3a05fe0a3a96 100
Highlights from the 38th SABCS annual meeting, 8th - 12th December 2015, San Antonio, USA, file dfa8b99b-edfa-748b-e053-3a05fe0a3a96 99
Effect of capmatinib on the pharmacokinetics of digoxin and rosuvastatin administered as a 2-drug cocktail in patients with MET-dysregulated advanced solid tumours: A phase I, multicentre, open-label, single-sequence drug–drug interaction study, file dfa8b9a6-5e58-748b-e053-3a05fe0a3a96 99
Immune approaches to the treatment of breast cancer, around the corner?, file dfa8b99b-1511-748b-e053-3a05fe0a3a96 98
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer, file dfa8b9a2-1521-748b-e053-3a05fe0a3a96 97
Delivering Cancer Care during the COVID-19 Pandemic: Recommendations and Lessons Learned from ASCO Global Webinars, file dfa8b9a5-dfda-748b-e053-3a05fe0a3a96 96
Totale 26389
Categoria #
all - tutte 44112
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44112

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201883 0000 00 00 005231
2018/20191540 246975144 9158 5880 120153334334
2019/20204502 334255422473 408373 348357 420384373355
2020/20215799 279334273300 401389 403371 679683856831
2021/202210353 671829671932 1131624 846789 8676651517811
2022/20238136 47257214571113 700644 608661 6756565780
Totale 31203